Cover Image
市場調查報告書

睡眠呼吸中止症治療設備的進步

Advances in Therapeutic Devices for Sleep Apnea

出版商 Technical Insights (Frost & Sullivan) 商品編碼 366641
出版日期 內容資訊 英文 56 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
睡眠呼吸中止症治療設備的進步 Advances in Therapeutic Devices for Sleep Apnea
出版日期: 2016年07月25日 內容資訊: 英文 56 Pages
簡介

治療睡眠呼吸中止症的全球市場,由於未開發地區傳統治療的普及,過去10年展現出順利的持續成長。

本報告以睡眠呼吸中止症治療設備的進步為焦點,詳細闡明其市場佔有率,形式的技術創新,主要市場推動要素及課題,再彙整北美,歐洲,亞太地區各市場上傳統療法的使用率,醫療體制,替代療法的定位發展前途等相關之最新調查資訊。

第1章 摘要整理

  • 調查範圍
  • 調查方法
  • 重要發現

第2章 技術力與趨勢

  • 佔睡眠呼吸中止症案例超過8成的阻塞型睡眠呼吸中止症低呼吸症
  • CPRP (持續的陽壓呼吸器法) 替代治療成為阻塞型睡眠呼吸中止症低呼吸症對策之現時需求
  • CPAP (持續性陽壓呼吸法) 治療容易造成患者不遵醫囑
  • CPAP市場超過8成由2公司所佔
  • 由於比較臨床研究的不足CPAP預測將成為主流領導該領域
  • 因S9系列而位居CPAP市場第一的ResMed
  • CRAP的最新發展相關的Philips Respironics
  • 由於CRAP難遵醫囑而轉換到口腔內壓法的患者
  • 可整體有效減輕無呼吸·低呼吸指數的口腔用矯正器具
  • 由於可恆久解決而助長口腔用矯正器具趨勢
  • ApniCure的新發明可發揮呼吸道負壓效果
  • 擁有最廣泛下頜前方移動設備產品範圍的SomnoMed
  • 以刺激舌下神經為重點的夜間發作性肌張力不全症 (NPD) 的措施
  • 由於設備小型化而加速的神經刺激領域
  • 重視設備小型化和縮短手術時間的Nyxoah
  • 提供神經刺激標靶治療的Inspire Medical Systems
  • 以永遠脫離CPAP面罩為目標的ImThera Medical
  • 預料將削減傳統療法成本的非侵入性產品
  • 帶來閉塞型睡眠呼吸中止症治療嶄新治療法的Provent Sleep Therapy
  • Advanced Brain Monitoring公司的位置療法提供閉塞型睡眠呼吸中止症治療的新療法
  • 嚴重的閉塞型睡眠呼吸中止症案例需要外科性干預
  • 比較CPAP和口腔設備 (OA) 治療的外科手術評估

第3章 影響的評估與分析

  • 形成睡眠呼吸中止症治療市場的推動要素與課題
  • 技術進步關係到閉塞型睡眠呼吸中止症的替代療法
  • 患者對傳統療法的低醫囑遵守率是市場最大的障礙

第4章 新技術的普及

  • 為求擴大必須增加全球優待度的報酬模式
  • 北美市場保有治療睡眠呼吸中止症的最大客群

第5章 知識產權環境

  • CRAP市場上佔支配地位的ResMed和Philips Respironics
  • 神經刺激領域上專利申請數領先的Inspire Medical Systems
  • 在專利申請上衛為潮流的口腔設備
  • 在專利申請上反應低迷的外科手術選擇
  • 對新技術抱有與專利申請數量般莫大興趣的美國

第6章 機會評估

  • 為了提升患者對設備的遵守度,追蹤不可或缺
  • 可望提升睡眠品質的遠程醫療

第7章 主要聯繫處和專利

  • 全球專利
  • 全球專利
  • 全球專利
  • 全球專利
  • 主要的聯繫處
  • 法律上的免責聲明

第8章 關於FROST & SULLIVAN

目錄
Product Code: D711-01-00-00-00

Technology Advances, Trends and Strategic Perspectives Reckoned to Boost the Adoption of Multiple Treatment Options

The sleep apnea therapeutics market has witnessed constant growth in the last decade due to the penetration of conventional therapies in untapped regions of the world. However, it is the technological advancements that have led to the emergence of a number conventional therapies for sleep apnea treatment. Increasing patient non-compliance towards the conventional CPAP treatment has led to development of alternative treatments such as oral appliances, oral pressure therapy, neurostimulators, positional therapy devices, to name a few.This research service covers the scope of all the advancements in therapeutic devices for the treatment of sleep apnea. The research study covers the market share assessment of CPAPs, key innovators across all types of treatment devices and key drivers and challenges affecting this market.The research study further details the adoption of conventional modes of treatment in regions of North America, Europe and Asia-Pacific, explaining the healthcare structure and the likelihood of adoption of alternative treatment methods in these three regions of the world. Finally, the section on opportunity evaluation gives the reader a chance to understand the current status of the market, positioning of the newer alternatives and explore future possibilities.

Table of Contents

1. EXECUTIVE SUMMARY

  • 1.1. Scope of Research
  • 1.2. Research Process Methodology
  • 1.2. Research Methodology (continued)
  • 1.3. Key Findings

2. TECHNOLOGY CAPABILITY AND TRENDS

  • 2.1. Obstructive Sleep Apnea constitutes over 80% of the Sleep Apnea cases
  • 2.2. High Marked Demand for a CPAP Alternative to Treat OSA
  • 2.3. Adoption of CPAPs Hit due to Patient Non-Compliance
  • 2.4. Over 80% of the CPAP Market Share is Owned by Two Companies
  • 2.5. CPAPs Expected to Dominate due to Lack of Comparative Clinical Studies
  • 2.6. ResMed continues to Lead the CPAP Market with their S9 Series
  • 2.7. Philips Respironics offers one of the most Recent Advancements in CPAPs
  • 2.8. CPAP Non-compliance Leads Patients to Oral Pressure Therapy
  • 2.9. Oral Devices are Effective in Reducing Overall Apnea Hypopnea Index
  • 2.10. Preference Towards Oral Devices Increases as they Offer a Permanent Solution
  • 2.11. ApniCure's Invention works on Negative Airway Pressure
  • 2.12. SomnoMed offers the largest range of Mandibular Advancement Devices
  • 2.13. NPD Efforts Focus on Stimulation of the Hypoglossal Nerve
  • 2.14. Device Miniaturization Expected to Boost the Neurostimulation Segment
  • 2.15. Nyxoah focuses on Device Miniaturization and Reduced Surgery Time
  • 2.16. Inspire Medical Systems presents a Targeted Neurostimulation Therapy
  • 2.17. ImThera Medical aims to provide Permanent Freedom from CPAP Masks
  • 2.18. Non-invasive Offerings Expected to Cut Down Cost of Conventional Treatments
  • 2.19. Provent Sleep Therapy offers a Novel Approach to treat Obstructive Sleep Apnea
  • 2.20. Positional Therapy from Advanced Brain Monitoring provides a New Approach to treat OSA
  • 2.21. Surgical Interventions Imperative for Severe OSA Cases
  • 2.22. Assessment of Surgery in Comparison to CPAPs and OAs

3. IMPACT ASSESSMENT AND ANALYSIS

  • 3.1. Drivers and Challenges shaping the Sleep Apnea Treatment Market
  • 3.2. Advancements in Technology Leading to a Rise in Alternative Therapies for OSA Treatment
  • 3.3. Poor Patient Compliance with Conventional Therapies is the Biggest Obstacle in the Sleep Apnea Market

4. DIFFUSION OF INNOVATIONS

  • 4.1. Reimbursements Models Need to be More Favorable Globally to Promote Adoption
  • 4.2. North American Market remains the Top Consumer of Sleep Apnea Therapies

5. IP LANDSCAPE

  • 5.1. ResMed and Philips Respironics continue to Rule the CPAP market
  • 5.2. Inspire Medical Systems leads the Patent filings in the Neurostimulation segment
  • 5.3. Oral Appliances witness continued trends in Patent Applications
  • 5.4. Surgery options witness a slow response in Patent filings
  • 5.5. USA generates maximum interest in Novel Technologies, as demonstrated by the Trend in Patent Applications

6. OPPORTUNITY EVALUATION

  • 6.1. Adherence Tracking is Crucial to Improve Patient Compliance with Devices
  • 6.2. Telemedicine to Help Improve the Quality of Sleep

7. KEY CONTACTS AND PATENTS

  • 7.1. Global Patents
  • 7.1. Global Patents
  • 7.1. Global Patents
  • 7.1. Global Patents
  • 7.2. Key Contacts
  • 7.3. Legal Disclaimer

8. THE FROST & SULLIVAN STORY

  • The Frost & Sullivan Story
  • Value Proposition: Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360° Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy
Back to Top